These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12868263)

  • 1. [Proteolysis directed by the extracellular matrix].
    Hornebeck W; Emonard H; Maquart FX; Bellon G
    J Soc Biol; 2003; 197(1):25-30. PubMed ID: 12868263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia.
    Clark ES; Whigham AS; Yarbrough WG; Weaver AM
    Cancer Res; 2007 May; 67(9):4227-35. PubMed ID: 17483334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular smooth muscle cells efficiently activate a new proteinase cascade involving plasminogen and fibronectin.
    Houard X; Monnot C; Dive V; Corvol P; Pagano M
    J Cell Biochem; 2003 Apr; 88(6):1188-201. PubMed ID: 12647301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrikines in the regulation of extracellular matrix degradation.
    Maquart FX; Bellon G; Pasco S; Monboisse JC
    Biochimie; 2005; 87(3-4):353-60. PubMed ID: 15781322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia.
    Poincloux R; Lizárraga F; Chavrier P
    J Cell Sci; 2009 Sep; 122(Pt 17):3015-24. PubMed ID: 19692588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model.
    Karagiannis ED; Popel AS
    J Theor Biol; 2006 Jan; 238(1):124-45. PubMed ID: 16005020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MT1-MMP releases latent TGF-beta1 from endothelial cell extracellular matrix via proteolytic processing of LTBP-1.
    Tatti O; Vehviläinen P; Lehti K; Keski-Oja J
    Exp Cell Res; 2008 Aug; 314(13):2501-14. PubMed ID: 18602101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth factors in the regulation of plasminogen-plasmin system in tumor cells.
    Keski-Oja J; Koli K; Lohi J; Laiho M
    Semin Thromb Hemost; 1991 Jul; 17(3):231-9. PubMed ID: 1839081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP).
    Osenkowski P; Toth M; Fridman R
    J Cell Physiol; 2004 Jul; 200(1):2-10. PubMed ID: 15137052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane associated matrix metalloproteinases in metastasis.
    Ellerbroek SM; Stack MS
    Bioessays; 1999 Nov; 21(11):940-9. PubMed ID: 10517867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial regulation of matrixmetalloproteinases and their inhibitors, fibrillar collagens and transforming growth factor-beta by Polypodium leucotomos, directly or in dermal fibroblasts, ultraviolet radiated fibroblasts, and melanoma cells.
    Philips N; Conte J; Chen YJ; Natrajan P; Taw M; Keller T; Givant J; Tuason M; Dulaj L; Leonardi D; Gonzalez S
    Arch Dermatol Res; 2009 Aug; 301(7):487-95. PubMed ID: 19373483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients.
    Ergul A; Portik-Dobos V; Hutchinson J; Franco J; Anstadt MP
    Am J Hypertens; 2004 Sep; 17(9):775-82. PubMed ID: 15363819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmin-matrix metalloproteinase cascades in spinal response to an experimental disc lesion in pig.
    Salo J; Mackiewicz Z; Indahl A; Konttinen YT; Holm AK; Sukura A; Holm S
    Spine (Phila Pa 1976); 2008 Apr; 33(8):839-44. PubMed ID: 18404101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane-type 1 matrix metalloproteinase modulates focal adhesion stability and cell migration.
    Takino T; Watanabe Y; Matsui M; Miyamori H; Kudo T; Seiki M; Sato H
    Exp Cell Res; 2006 May; 312(8):1381-9. PubMed ID: 16473349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the protease activity that cleaves the extracellular domain of beta-dystroglycan.
    Zhong D; Saito F; Saito Y; Nakamura A; Shimizu T; Matsumura K
    Biochem Biophys Res Commun; 2006 Jun; 345(2):867-71. PubMed ID: 16701552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MT1-MMP: a potent modifier of pericellular microenvironment.
    Itoh Y; Seiki M
    J Cell Physiol; 2006 Jan; 206(1):1-8. PubMed ID: 15920734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation.
    Chen CL; Huang SK; Lin JL; Lai LP; Lai SC; Liu CW; Chen WC; Wen CH; Lin CS
    J Mol Cell Cardiol; 2008 Dec; 45(6):742-53. PubMed ID: 18692064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour invasion and matrix metalloproteinases.
    Polette M; Nawrocki-Raby B; Gilles C; Clavel C; Birembaut P
    Crit Rev Oncol Hematol; 2004 Mar; 49(3):179-86. PubMed ID: 15036258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of melanoma progression by various matrikines from basement membrane macromolecules.
    Pasco S; Ramont L; Maquart FX; Monboisse JC
    Crit Rev Oncol Hematol; 2004 Mar; 49(3):221-33. PubMed ID: 15036262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration.
    Fujiwara M; Muragaki Y; Ooshima A
    Br J Dermatol; 2005 Aug; 153(2):295-300. PubMed ID: 16086739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.